Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -110.78M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 23,600
Avg Vol 30,360
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 64%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It...

Phone: 919 313 9633
Address:
2525 East North Carolina Highway 54, Durham, United States
Latest News on HUMAW
Humacyte To Participate in Upcoming Investor Conferences

Mar 2, 2026, 8:00 AM EST - 6 weeks ago

Humacyte To Participate in Upcoming Investor Conferences


Trestle Bio Announces Research Collaboration with Humacyte

Mar 6, 2025, 8:00 AM EST - 1 year ago

Trestle Bio Announces Research Collaboration with Humacyte